Dr. Vikram C. Gorantla, a medical oncologist at College of Pittsburgh Medical Middle, discusses key issues for sufferers with mind metastases resulting...
The U.S. Meals and Drug Administration (FDA) has granted accelerated approval to the CD20xCD3 bispecific antibody Lunsumio VELO (mosunetuzumab), as a subcutaneous...
Lynozyfic (linvoseltamab), a B-cell maturation antigen and CD3 bispecific antibody, confirmed a excessive total response fee and a tolerable security profile when...
